CEO and Chairman of Adaptive Biotechnologies Corp (NASDAQ:ADPT), Robins Chad M, sells 10,000 shares worth $627,648
According to Adaptive Biotechnologies Corp's most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Feb 10 09:00 PM, company CEO and Chairman, Robins Chad M disclosed selling 10,000 shares at a cost of $62.76. At the time of this transaction (Feb 10), this trade was worth $627,648 in total. As of Feb 10, Robins Chad M now owns 1,709,780 shares in total worth about $107,339,988.4.
For the last few recent trades made by Adaptive Biotechnologies Corp (NASDAQ:ADPT) CEO and Chairman, Robins Chad M, we have the following information:
- SEC Form 4 filing: Jan 19: Sold 8,400 shares at the rate of $70.43 per share. Total worth of this trade was $591,600. Total number of shares owned as of Jan 19 were 1,769,780
- SEC Form 4 filing: Dec 28: Sold 16,250 shares at the rate of $60.95 per share. Total worth of this trade was $990,496. Total number of shares owned as of Dec 28 were 1,778,180
- SEC Form 4 filing: Dec 29: Sold 16,790 shares at the rate of $59.28 per share. Total worth of this trade was $995,348. Total number of shares owned as of Dec 29 were 1,778,180
Posted by
George Daniels
on Wednesday February 10 2021, 11:44 PM EDT.
All trademarks acknowledged.
Filed under Business, Stocks.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
